Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol reduction: weighing the benefits and risks

J M Gaziano1, P R Hebert, C H Hennekens

  • 1Brigham and Women's Hospital, Division of Preventive Medicine, Boston, MA 02215-1204, USA.

Annals of Internal Medicine
|May 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective study of blood pressure and risk of cataract in men.

Annals of epidemiology·2001
Same author

G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.

Journal of the American College of Cardiology·2001
Same author

Relations of body fat distribution and height with cataract in men.

The American journal of clinical nutrition·2000
Same author

Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men.

Hypertension (Dallas, Tex. : 1979)·2000
Same author

An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease.

Archives of internal medicine·2000
Same author

Clinical and research challenges in risk factors for cardiovascular diseases.

European heart journal·2000

Lowering cholesterol, particularly low-density lipoprotein (LDL) cholesterol, is recommended to reduce coronary heart disease risk. Evidence supports cholesterol reduction benefits without increasing nonvascular mortality risks.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • The National Cholesterol Education Program (NCEP) guidelines aim to reduce coronary heart disease (CHD) risk.
  • Elevated cholesterol levels, specifically total and low-density lipoprotein (LDL) cholesterol, are established risk factors for CHD.

Purpose of the Study:

  • To evaluate the evidence supporting cholesterol reduction for decreasing CHD risk.
  • To assess the relationship between cholesterol reduction and nonvascular causes of death.
  • To determine the justification and warrant for current NCEP recommendations.

Main Methods:

  • Review of existing scientific evidence and data from clinical trials.
  • Analysis of the association between cholesterol levels and CHD incidence.

Related Experiment Videos

  • Examination of data regarding nonvascular mortality in relation to cholesterol-lowering interventions.

    • Main Results:

    • Strong evidence indicates higher cholesterol levels increase CHD risk.
    • Cholesterol reduction demonstrably decreases CHD risk.
    • Current data do not strongly link cholesterol reduction to increased nonvascular mortality.

    Conclusions:

    • Current NCEP recommendations for cholesterol management are justified and warranted.
    • Nonpharmacologic interventions and cholesterol-reducing drugs are recommended for specific adult populations.
    • Ongoing large-scale trials will further refine guidelines for cholesterol management.